PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-Jul-2024 Meet Gaelic Laboratories, your trusted testing and manufacturing partner Gaelic Laboratories
11-Jul-2024 CureVac Provides Update on Trial Dates for Patent Litigation Across Multiple Geographies Against Pfizer/BioNTech CureVac
11-Jul-2024 Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity Biophytis
11-Jul-2024 Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business Heidelberg Pharma AG
11-Jul-2024 Gerresheimer remains on track in 1st half year 2024 Gerresheimer AG
11-Jul-2024 DocMorris with accelerated and significant eRx growth in new customers, market share and revenue DocMorris AG
10-Jul-2024 Evotec and Pfizer collaborate to advance drug discovery in France Evotec SE
10-Jul-2024 Viromed Medical AG seeks special approval for cold plasma device for the prevention of ventilator-associated pneumonia (VAP) Viromed Medical AG
10-Jul-2024 Uni-Bio Science And Chongqing Minji Establish Strategic Partnership, Targeting Hundreds Of Billions Of Yuan of Medical Aesthetics Device Market UNI-BIO SCIENCE GROUP LIMITED
10-Jul-2024 Marcel Imwinkelried appointed as new CEO Siegfried AG
09-Jul-2024 IMFINZI▼(DURVALUMAB) IN COMBINATION WITH CHEMOTHERAPY APPROVED IN GREAT BRITAIN FOR THE TREATMENT OF RESECTABLE NON-SMALL CELL LUNG CANCER AstraZeneca
09-Jul-2024 Immunic Appoints Jason Tardio as Chief Operating Officer and President (news with additional features) Immunic AG
09-Jul-2024 Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test   Mainz BioMed N.V.
09-Jul-2024 Cantourage Group SE shows strong business performance and high growth momentum in the first half of 2024 Cantourage Group SE
09-Jul-2024 Basel, 9th July 2024   Matthias Schupp appointed as CEO of Medartis Medartis Holding AG
08-Jul-2024 APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million APEIRON Biologics AG
08-Jul-2024 Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz Evotec SE
08-Jul-2024 DEFENCE RECEIVES NO OBJECTION LETTER FROM HEALTH CANADA FOR PHASE I TRIAL OF ITS ACCUM-002 (ACCUTOX) AS AN ANTI-CANCER MOLECULE IN PATIENTS WITH MELANOMA Defence Therapeutics Inc.
08-Jul-2024 Spexis AG: PARI Pharma GmbH announces termination of ColiFin® license to EnBiotix, Inc. Spexis AG
05-Jul-2024 Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH terminate their cooperation with immediate effect Viromed Medical AG